Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1327437

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1327437

Insulin Delivery Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

PUBLISHED:
PAGES: 253 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4000
PDF (Site License)
USD 8000
PDF (Global License)
USD 12000

Add to Cart

Abstract

GlobalData's Medical Devices sector report, "Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Insulin Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Insulin delivery devices are used to inject measured doses of insulin through the skin and into the fatty tissues below.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Insulin Delivery under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Insulin Delivery and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Insulin Delivery under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Product Code: GDME1585EPD

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Insulin Delivery Overview

3 Products under Development

  • 3.1 Insulin Delivery - Pipeline Products by Stage of Development
  • 3.2 Insulin Delivery - Pipeline Products by Segment
  • 3.3 Insulin Delivery - Pipeline Products by Territory
  • 3.4 Insulin Delivery - Pipeline Products by Regulatory Path
  • 3.5 Insulin Delivery - Pipeline Products by Estimated Approval Date
  • 3.6 Insulin Delivery - Ongoing Clinical Trials

4 Insulin Delivery - Pipeline Products under Development by Companies

  • 4.1 Insulin Delivery Companies - Pipeline Products by Stage of Development
  • 4.2 Insulin Delivery - Pipeline Products by Stage of Development

5 Insulin Delivery Companies and Product Overview

6 Insulin Delivery- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!